In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
The World Health Organization (WHO) has declared the global situation regarding MPX to be a public health emergency of international concern.
Since May 2022, there has been a global increase in MPX infections in multiple countries where the illness is not usually seen. The situation is evolving quickly, and health authorities are monitoring closely so the most up to date evidence and advice can be provided.
Australia’s MPX situation
The unfolding situation in Australia concerning MPX is being monitored closely by health authorities. The current status as of 24 July 2022, is 44 confirmed and probable cases of MPX in Australia, with 24 cases in New South Wales. Most, but not all, cases recorded in Australia have been acquired overseas.
Monkeypox has been added to the list of notifiable diseases under the Public Health Act 2010. Healthcare professionals must notify any suspected cases of MPX to the local Public Health Unit on 1300 066 055 immediately to initiate a public health investigation, contact tracing and control measures.
The management of suspected cases for general practitioners
If monkeypox is suspected, immediately notify the on-call Westmead Hospital Infectious Disease Specialist on 8890 5555 to discuss the case and management.
What is MPX?
Monkeypox (MPX) is a disease caused by Monkeypox virus (MPXV), with symptoms similar to those seen previously with smallpox. It is spread through close contact with an infected person or animals, or with contaminated material. Find out more.
ATAGI clinical guidance on vaccination against Monkeypox: ATAGI has updated clinical guidance on the use of smallpox vaccine vaccination against monkeypox. Two vaccines are available in Australia for prevention of monkeypox: the 3rd generation JYNNEOS® (MVA-BN: modified vaccinia Ankara vaccine-Bavarian Nordic) and the 2nd generation ACAM2000™
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…